CompaniesBanner Life Sciences

Banner Life Sciences

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

5

As Collaborator

0

Total Enrollment

331

By Phase

PHASE1: 3

By Status

COMPLETED: 3TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details

Recent Trials

NCT05978531Lead Sponsor
Observational Study of Persistence on Bafiertam Treatment in Routine Clinical Practice
N/ATerminated
25 participants
Started: Aug 17, 2023 · Completed: Feb 24, 2025
NCT04925778Lead Sponsor
Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate
N/AWithdrawn
Started: Jun 30, 2021 · Completed: Sep 29, 2022
NCT05181215Lead Sponsor
Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects
PHASE1Completed
46 participants
Started: May 14, 2021 · Completed: Aug 27, 2021
NCT04022473Lead Sponsor
Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers
PHASE1Completed
210 participants
Started: Jul 7, 2019 · Completed: Oct 19, 2019
NCT04570670Lead Sponsor
Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects
PHASE1Completed
50 participants
Started: Jan 6, 2017 · Completed: Feb 17, 2017
Related Companies
Cycle Pharma
acquired